These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8359345)

  • 61. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.
    Ciusani E; Allen M; Sandberg-Wollheim M; Eoli M; Salmaggi A; Milanese C; Nespolo A; Gyllensten U
    Eur J Immunogenet; 1995 Apr; 22(2):171-8. PubMed ID: 7605774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease.
    Cuddihy RM; Bahn RS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):847-9. PubMed ID: 8636314
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HLA-DRB1, DQB1, and DQA1 allele profile in Brazilian patients with type 1 diabetes mellitus.
    Fernandes AP; Louzada-Junior P; Foss MC; Donadi EA
    Ann N Y Acad Sci; 2002 Apr; 958():305-8. PubMed ID: 12021129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HLA-DQ and TAP2 genes in patients with insulin-dependent diabetes mellitus.
    Lotfi M; Sastry A; Ye M; VanderMeulen J; Dosch HM; Singal DP
    Immunol Lett; 1994 Jul; 41(2-3):201-4. PubMed ID: 8002038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HLA-DR and -DQ polymorphism in Cameroon.
    Pimtanothai N; Hurley CK; Leke R; Klitz W; Johnson AH
    Tissue Antigens; 2001 Jul; 58(1):1-8. PubMed ID: 11580849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201.
    Ploski R; Ek J; Thorsby E; Sollid LM
    Tissue Antigens; 1993 Apr; 41(4):173-7. PubMed ID: 8362409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
    Todd JA; Bell JI; McDevitt HO
    Nature; 1987 Oct 15-21; 329(6140):599-604. PubMed ID: 3309680
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allelic diversity at class II DRB1 and DQB loci of the pig MHC (SLA).
    Kanai TH; Tanioka Y; Tanigawa M; Matsumoto Y; Ueda S; Onodera T; Matsumoto Y
    Immunogenetics; 1999 Dec; 50(5-6):295-300. PubMed ID: 10630293
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DRw52-group haplotypes are frequent acceptors of DRw15-Dw2 DQ genes in DQA1-DRB1 recombination.
    Santamaria P; Noreen HJ; Lindstrom AL; Barbosa JJ; Faras AJ; Segall M; Rich SS
    Immunogenetics; 1992; 36(1):56-63. PubMed ID: 1350268
    [No Abstract]   [Full Text] [Related]  

  • 70. Two novel HLA-DQB1*06 alleles reveal additional heterogeneity of HLA-DQw1.
    Fenske TS; Baxter-Lowe LA
    Tissue Antigens; 1992 Jul; 40(1):49-52. PubMed ID: 1440562
    [No Abstract]   [Full Text] [Related]  

  • 71. HLA DRB1-DQA1-DQB1 haplotype diversity in two African populations.
    Schnittger L; May J; Loeliger CC; Gallin MY; Erttmann KD; Bienzle U; Kremsner PG; Meyer CG
    Tissue Antigens; 1997 Nov; 50(5):546-51. PubMed ID: 9389330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DR and DQ beta cDNA sequences associated with a DR2 haplotype.
    Hurley CK; Ziff BL; Steiner N; Gregersen PK; Silver J
    Hum Immunol; 1988 Jul; 22(3):179-83. PubMed ID: 3139589
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
    Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
    J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular analysis of HLA-DRB1, -DQA1 and -DQB1 polymorphism in Turkey.
    Saruhan-Direskeneli G; Uyar FA; Bakar S; Eraksoy M
    Tissue Antigens; 2000 Feb; 55(2):171-4. PubMed ID: 10746791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
    Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contribution of HLA class II genes to susceptibility in achalasia.
    De la Concha EG; Fernandez-Arquero M; Mendoza JL; Conejero L; Figueredo MA; Perez de la Serna J; Diaz-Rubio M; Ruiz de Leon A
    Tissue Antigens; 1998 Oct; 52(4):381-4. PubMed ID: 9820602
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
    Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
    Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Restriction enzyme analysis of HLA class II DR beta genes in patients with Graves' disease.
    Boehm BO; Schifferdecker E; Kuehnl P; Rosak C; Schöffling K
    Acta Endocrinol Suppl (Copenh); 1987; 281():146-8. PubMed ID: 3039771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.